ARCHIVES

The Cancer Letter takes two-week break; next issue Jan. 2.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Epstein Petition Seeks Broder’s Removal As NCI Director

February 5, 1993

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

Advanced Screening Provides More Accurate Diagnosis

February 23, 2007

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014